[
  {
    "ts": null,
    "headline": "Biogen Inc. stock underperforms Friday when compared to competitors",
    "summary": "Biogen Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=87fb6a8318b3d60752a9b87ada032df31dc03d1e5041d40eafabfa52ca0bbcee",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731690360,
      "headline": "Biogen Inc. stock underperforms Friday when compared to competitors",
      "id": 131428423,
      "image": "",
      "related": "BIIB",
      "source": "MarketWatch",
      "summary": "Biogen Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=87fb6a8318b3d60752a9b87ada032df31dc03d1e5041d40eafabfa52ca0bbcee"
    }
  },
  {
    "ts": null,
    "headline": "Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe",
    "summary": "The CHMP renders a positive opinion recommending approval for BIIB and Eisai's Leqembi for treating early Alzheimer's disease.",
    "url": "https://finnhub.io/api/news?id=1350f1a765898814cfdafda3a8ff5af9fde1eb04128938c4481e9bf7fc7b9a03",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731679440,
      "headline": "Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe",
      "id": 131375206,
      "image": "https://media.zenfs.com/en/zacks.com/7d0183f93b51892d562cc8047433f507",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "The CHMP renders a positive opinion recommending approval for BIIB and Eisai's Leqembi for treating early Alzheimer's disease.",
      "url": "https://finnhub.io/api/news?id=1350f1a765898814cfdafda3a8ff5af9fde1eb04128938c4481e9bf7fc7b9a03"
    }
  }
]